TY - STD TI - Koehler G, Treiber G, Wutte A, Korsatko S, Mader JK, Semlitsch B, et al. Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes. Diabetes Obes Metab. 2014; doi:10.1111/dom.12178. ID - ref1 ER - TY - JOUR AU - Heise, T. AU - Nosek, L. AU - Bottcher, S. G. AU - Hastrup, H. AU - Haahr, H. PY - 2012 DA - 2012// TI - Ultra-long-acting insulin deguludec has a flat and stable glucose-lowering effect in type 2 diabetes JO - Diabetes Obes Metab. VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01638.x DO - 10.1111/j.1463-1326.2012.01638.x ID - Heise2012 ER - TY - JOUR AU - Jonassen, I. AU - Havelund, S. AU - Hoeg-Jensen, T. AU - Steensgaard, D. B. AU - Wahlund, P. O. AU - Ribel, U. PY - 2012 DA - 2012// TI - Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin JO - Pharm Res. VL - 29 UR - https://doi.org/10.1007/s11095-012-0739-z DO - 10.1007/s11095-012-0739-z ID - Jonassen2012 ER - TY - JOUR AU - Heller, S. AU - Buse, J. AU - Fisher, M. AU - Garg, S. AU - Marre, M. AU - Merker, L. AU - Renard, E. AU - Russell-Jones, D. AU - Philotheou, A. AU - Francisco, A. M. AU - Pei, H. AU - Bode, B. PY - 2012 DA - 2012// TI - Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomized, open-label, treat-to-target non-inferiority trial JO - Lancet. VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60204-9 DO - 10.1016/S0140-6736(12)60204-9 ID - Heller2012 ER - TY - JOUR AU - Zinman, B. AU - Philis-Tsimikas, A. AU - Cariou, B. AU - Handelsman, Y. AU - Rodbard, H. W. AU - Johansen, T. AU - Endahl, L. AU - Mathieu, C. PY - 2012 DA - 2012// TI - Trial Inbestigators. Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long) JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc12-1205 DO - 10.2337/dc12-1205 ID - Zinman2012 ER - TY - JOUR AU - Davies, M. J. AU - Gross, J. L. AU - Ono, Y. AU - Sasaki, T. AU - Bantwal, G. AU - Gall, M. A. AU - Niemeyer, M. AU - Seino, H. PY - 2014 DA - 2014// TI - Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial JO - Diabetes Obes Metab. VL - 16 UR - https://doi.org/10.1111/dom.12298 DO - 10.1111/dom.12298 ID - Davies2014 ER - TY - JOUR AU - Ishii, H. PY - 2012 DA - 2012// TI - Development and psychometric validation of the diabetes therapy-related QOL questionnaire JO - Journal of Medical Economics. VL - 15 UR - https://doi.org/10.3111/13696998.2012.665111 DO - 10.3111/13696998.2012.665111 ID - Ishii2012 ER - TY - JOUR AU - Dhatt, G. S. AU - Agarwal, M. M. AU - Bishawi, B. PY - 2005 DA - 2005// TI - HbA1c: a comparison of NGSP with IFCC transformed values JO - Clin Chim Acta. VL - 358 UR - https://doi.org/10.1016/j.cccn.2005.02.009 DO - 10.1016/j.cccn.2005.02.009 ID - Dhatt2005 ER - TY - STD TI - Mashitani T, Hayashino Y, Okamura S, Kitatani M, Furuya M, Iburi T, et al. Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8). Acta Diabetol. 2015;doi:10.1007/s00592-015-0725-0. ID - ref9 ER - TY - JOUR AU - Francesca, P. AU - Paolo, R. AU - Natalia, R. B. AU - Stefania, M. AU - Paola, L. AU - Steven, L. AU - David, R. O. AU - Geremia, B. B. AU - Carmine, G. F. PY - 2007 DA - 2007// TI - Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes JO - Diabetes Care. VL - 30 UR - https://doi.org/10.2337/dc07-0002 DO - 10.2337/dc07-0002 ID - Francesca2007 ER - TY - JOUR AU - Meneghini, L. AU - Atkin, S. L. AU - Gough, S. C. AU - Raz, I. AU - Blonde, L. AU - Shestakova, M. AU - Bain, S. AU - Johansen, T. AU - Begtrup, K. AU - Birkeland, K. I. PY - 2013 DA - 2013// TI - The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes JO - Diabetes Care. VL - 22 UR - https://doi.org/10.2337/dc12-1668 DO - 10.2337/dc12-1668 ID - Meneghini2013 ER - TY - JOUR AU - Oyer, D. AU - Narendran, P. AU - Qvist, M. AU - Nadeau, D. A. PY - 2011 DA - 2011// TI - Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses JO - Expert Opin Drug Deliv. VL - 10 UR - https://doi.org/10.1517/17425247.2011.615830 DO - 10.1517/17425247.2011.615830 ID - Oyer2011 ER - TY - JOUR AU - Bailey, T. AU - Thurman, J. AU - Niemeyer, M. AU - Schmeisl, G. PY - 2011 DA - 2011// TI - Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals JO - Curr Med Res Opin. VL - 10 UR - https://doi.org/10.1185/03007995.2011.616190 DO - 10.1185/03007995.2011.616190 ID - Bailey2011 ER - TY - JOUR AU - Garg, S. AU - Bailey, T. AU - Delusio, T. AU - Pollom, D. PY - 2011 DA - 2011// TI - Preference for a new prefilled insulin pen compared with the original pen JO - Curr Med Res Opin. VL - 12 UR - https://doi.org/10.1185/03007995.2011.630721 DO - 10.1185/03007995.2011.630721 ID - Garg2011 ER -